Greater China grabs top spots in VC deals as activity hits record highs in 2018

By
Posted

Nine of the top ten deals in the year came from Asia of which seven were in China, according to a Preqin report.

Frequency Therapeutics secures $42m from Taiwania Capital, Axil, others

By

The round was joined by existing backers Polaris Founders Capital, Alexandria Venture Investments, CoBro Ventures, Korea Investment Partners and Emigrant Capital.


Asia bucks global trend, posts 42% growth in VC deal volume in 2018

By

Asia also accounted for four of the top six venture funding deals globally in Q4 of 2018.


China’s Morningside leads $40m funding in gene therapy developer Apic Bio

By

Launched in August 2017, Apic Bio is a spinoff from the University of Massachusetts Medical School.


Shenzhen Capital hits first close at $262m for its $525m debut M&A fund

By

Investors in the fund include Shenzhen Capital Group, Shenzhen City Guidance Fund, UTrust Fund, Shenzhen Huitong Financial Holdings and others.


Chinese diabetes device platform completes $100m Series C round

By

The latest series C2 round was led by CICC Capital and CLP Group’s health fund and joined by Samsung Venture Investment, Tasly and Ping An Insurance.


Indian co-living startup Zolo raises $30m Series B led by IDFC Alternatives, Mirae Asset, Nexus

By

Zolo had last raised $5 million in its Series A funding from Nexus Ventures Partners in December 2016.


Dubai-based financial comparison platform yallacompare raises $8m

By

Argo Ventures, the investment arm of insurance company Argo Group, participated in the round as a new investor.


Google Launchpad’s India accelerator to continue focus on AI startups

By

Agriculture and healthcare technology are two strong emerging themes in India which Google Launchpad is likely to back in the future.


India’s 021 Capital said to reach first close of maiden fund at $32m

By

021 Capital was launched in 2017 by Flipkart founders’ personal investment adviser Shailesh Tulshan with a target of $50 million.